Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 153
Filter
1.
Cancer Radiother ; 16(8): 688-96, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23153504

ABSTRACT

PURPOSE: In 1998 a translational research was initiated in Lyon aiming at identifying a prognostic "biomolecular signature" in rectal cancer. This paper presents the clinical outcome of the patients included in this study. PATIENTS AND METHODS: A total of 94 patients were included between 1998 and 2001. A staging with rectoscopy and biopsies was performed before treatment. In case of surgery, the operative specimen was analysed to evaluate the pathological response. There were two types of treatment: neoadjuvant radiotherapy (with or without concurrent chemotherapy) followed by surgery (76 cases) and radiotherapy alone with 'contactherapy' often associated with external beam radiotherapy (18 patients). RESULTS: The patients had a mean age of 63years. Stage was T1: 4, T2: 24, T3: 65 and T4: 1. The overall survival of the 94 patients was 62% at 8years with a rate of distant metastases of 29%. Rate of local recurrence at 8years was 6% in the neoadjuvant group and 16% in the radiotherapy group with an overall 8years survival in both groups respectively: 64% and 53%. There was a trend towards more metastases in cT3, tumour diameter above 4cm, circumferential extension. There was a significant increase in the risk of metastases for ypT3, ypN1-2 and Dworak score 1-2-3. In multivariate analysis ypT3 was significantly associated with a high rate of metastases (55%; P=0.0003). CONCLUSION: The rate of distant metastases is a major prognostic factor. These clinical results will serve as the base line to identify a "biomolecular signature" which could complement the TN(M) classification.


Subject(s)
Rectal Neoplasms/mortality , Rectal Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Carcinoma/mortality , Carcinoma/pathology , Carcinoma/therapy , Chemotherapy, Adjuvant , Female , Humans , Male , Middle Aged , Multivariate Analysis , Neoadjuvant Therapy , Neoplasm Metastasis , Neoplasm Recurrence, Local , Neoplasm Staging , Prognosis , Prospective Studies , Radiotherapy, Adjuvant , Rectal Neoplasms/pathology , Risk Assessment
2.
J Visc Surg ; 149(1): e11-22, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22154179

ABSTRACT

Abdominal approach is commonly used for resection of liver tumors. However, in rare cases, transthoracic approach may be a valuable option for management of lesions located in the hepatic dome or involving the cavo-hepatic junction for very selected patients. This approach can be an open procedure (thoracotomomy), a video-assisted minimally invasive technique (thoracoscopy), or a strictly percutaneously treatment (CT-guided radiofrequency ablation). This approach seems useful for high-risk patients, with previous major abdominal surgery, or awaiting for liver transplantation (bridge concept) with cranially located single lesions. A limited liver resection (tumorectomy or segmentectomy) can be performed, but this approach is also suitable for percutaneous ablation therapy (radiofrequency or cryotherapy), with an acceptable morbidity.


Subject(s)
Catheter Ablation , Hepatectomy/methods , Liver Neoplasms/surgery , Thoracic Surgery, Video-Assisted , Thoracotomy , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/surgery , Cryosurgery , Humans , Laparotomy , Liver Neoplasms/complications , Liver Neoplasms/pathology , Phrenic Nerve/surgery , Sternotomy , Treatment Outcome
3.
J Visc Surg ; 148(5): e346-52, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22033151

ABSTRACT

Chylothorax is a rare but severe complication of thoracic and esophageal surgery. The anatomical relations of the thoracic duct and its highly variable anatomy may explain the occurrence of thoracic duct injury during dissection of the posterior mediastinum. At an early stage, chylothorax can lead to severe cardiorespiratory and volemic complications. In case of chronicization, malnutrition and immunologic complications can occur, responsible for a mortality rate of up to 50%. Optimal management of chylothorax can decrease mortality. It is based on three options: conservative treatment, surgery and radiological treatment. Conservative treatment must be initiated at diagnosis and results in resolution of the chylothorax is achieved in 50 to 70% of cases. In case of either high flow rate chylothorax or failure of conservative treatment, reoperation is indicated. Percutaneous embolization is an interesting and minimally invasive alternative to surgery.


Subject(s)
Chylothorax/surgery , Thoracic Surgical Procedures/adverse effects , Chylothorax/diagnosis , Chylothorax/etiology , Esophagectomy/adverse effects , Humans , Postoperative Complications
4.
Clin Res Hepatol Gastroenterol ; 35(8-9): 586-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21397584

ABSTRACT

Pancreatic metastases from colorectal cancer are extremely rare. We report the case of a 74-years-old patient presented with a metachronous pancreatic metastasis, which was treated by segmental pancreatectomy. After reviewing literature, diagnosis and management of pancreatic metastasis from colorectal carcinoma are discussed.


Subject(s)
Adenocarcinoma/pathology , Colonic Neoplasms/pathology , Pancreatic Neoplasms/secondary , Aged , Humans , Male
5.
J Visc Surg ; 148(1): 19-26, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21310681

ABSTRACT

The goal of this review is to evaluate, through a review of the surgical literature, the role of esophagectomy in the management of Barrett's esophagus as it evolves histologically from intestinal metaplasia through increasing grades of dysplasia to adenocarcinoma. We precisely define the indications and therapeutic modalities of esophagectomy for high-grade dysplasia, superficial adenocarcinoma, and invasive adenocarcinoma.


Subject(s)
Adenocarcinoma/etiology , Adenocarcinoma/surgery , Barrett Esophagus/pathology , Barrett Esophagus/surgery , Esophagectomy , Adenocarcinoma/diagnosis , Adenocarcinoma/epidemiology , Disease Progression , Esophagus/pathology , Humans , Lymph Node Excision , Metaplasia , Mucous Membrane/pathology , Risk , Treatment Outcome , Video-Assisted Surgery
6.
Rev Epidemiol Sante Publique ; 59(1): 3-14, 2011 Feb.
Article in French | MEDLINE | ID: mdl-21237594

ABSTRACT

BACKGROUND: Surveillance is an effective element in the fight against nosocomial infections, but the monitoring methods are often cumbersome and time consuming. The detection of infection in computerized databases is a means to alleviate the workload of health care teams. The objective of this study was to evaluate the performance of using discharge summaries in medico-administrative databases (PMSI) for the identification of nosocomial infections in surgery, intensive care and obstetrics. METHODS: The retrospective assessment study included patients who were hospitalized in general surgery, intensive care and obstetrics at different periods of time in 2006 and 2007 depending on the wards. Patients were monitored according to standard protocols which are coordinated at the regional level by the Southeast coordinating centre (CCLIN). The performance of identifying cases of nosocomial infection from discharge diagnoses coded by using the International Classification of Diseases (tenth revision) was evaluated by a study of sensitivity, specificity, positive and negative predictive values with their 95% confidence intervals. RESULTS: Using a limited number of diagnostic codes, the sensitivity and specificity were, respectively, 26.3% (95% CI 13.2-42.1) and 99.5% (95% 98.8-100.0) for the identification of surgical site infections. By expanding the number of diagnostic codes, the sensitivity and specificity were 78.9% (95% CI 65.8-92.1) and 65.7% (95% CI 61.0-70.3). The sensitivity and specificity for case identification of nosocomial infections in intensive care were 48.8% (95% CI 42.6-55.0) and 78.4% (95% CI 76.1-80.1), and were 42.9% (95% CI 25.0-60.7) and 87.3% (95% CI 85.2-89.3) for identification of postpartum infections. CONCLUSION: The PMSI is not a sufficiently efficient method in terms of sensitivity to be used in surveillance of nosocomial infections. A reassessment of the PMSI must be considered, with changes in coding of comorbidity that occurred in 2009.


Subject(s)
Cross Infection/epidemiology , Databases as Topic , Female , France/epidemiology , Hospitals, University , Humans , International Classification of Diseases , Male , Middle Aged , Population Surveillance , Retrospective Studies , Sensitivity and Specificity
8.
Am J Transplant ; 8(6): 1205-13, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18444921

ABSTRACT

Liver transplantation (LTx) for metastatic endocrine tumors (MET) remains controversial due to the lack of clear selection criteria. From 1989 to 2005, 85 patients underwent LTx for MET. The primary tumor was located in the pancreas or duodenum in 40 cases, digestive tract in 26 and bronchial tree in five. In the remaining 14 cases, primary location was undetermined at the time of LTx. Hepatomegaly (explanted liver > or =120% of estimated standard liver volume) was observed in 53 patients (62%). Extrahepatic resection was performed concomitantly with LTx in 34 patients (40%), including upper abdominal exenteration (UAE) in seven. Postoperative in-hospital mortality was 14%. Overall 5-year survival was 47%. Independent factors of poor prognosis according to multivariate analysis included UAE (relative risk (RR): 3.72), primary tumor in duodenum or pancreas (RR: 2.94) and hepatomegaly (RR: 2.63). After exclusion of cases involving concomitant UAE, the other two factors were combined into a risk model. Five-year survival rate was 12% for the 23 patients presenting both unfavorable prognostic factors versus 68% for the 55 patients presenting one or neither factor (p < 10(-7)). LTx can benefit selected patients with nonresectable MET. Patients presenting duodeno-pancreatic MET in association with hepatomegaly are poor indications for LTx.


Subject(s)
Endocrine Gland Neoplasms/surgery , Liver Neoplasms/surgery , Liver Transplantation/mortality , Neuroendocrine Tumors/surgery , Adolescent , Adult , Endocrine Gland Neoplasms/secondary , Female , France , Humans , Liver Neoplasms/secondary , Male , Middle Aged , Neuroendocrine Tumors/secondary , Prognosis , Retrospective Studies , Survival Analysis
9.
Gastroenterol Clin Biol ; 32(4): 378-81, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18403153

ABSTRACT

UNLABELLED: Wilson's disease is a hereditary defect in hepatic copper metabolism, causing hepatic, neurological and/or psychiatric manifestations. For patients with severe disease, liver transplantation is the treatment of choice. The aim of this study was to report the long-term outcome of patients who underwent liver transplantation for Wilson's disease. PATIENTS AND METHODS: Thirteen patients with Wilson's disease, transplanted in Lyon France between January 1987 and May 2006, were including in this study: eight women and five men, aged eight to 53 years (median 20 years, seven children and six adults). The diagnosis of Wilson's disease was established before liver transplantation. RESULTS: The indication for liver transplantation was chronic (69%) or fulminant liver failure (31%). The median follow-up after liver transplantation was 10 years with 100% patient survival. Copper metabolism returned to normal in all patients. None of the patients with exclusive liver disease required chelation treatment after liver transplantation and none developed neurological symptoms of Wilson's disease. CONCLUSION: Liver transplantation totally reverses the abnormalities of copper metabolism and subsequent hepatic failure, but the course of neurological symptoms remains unpredictable. Long-term patient survival can be excellent without occurrence of neurological complications.


Subject(s)
Hepatolenticular Degeneration/surgery , Liver Transplantation , Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Time Factors , Treatment Outcome
10.
Gastroenterol Clin Biol ; 32(1 Pt. 1): 74-8, 2008 Jan.
Article in French | MEDLINE | ID: mdl-18405652

ABSTRACT

Bleeding from a pseudoaneurysm is a rare complication of chronic pancreatitis. We present two cases of ruptured pseudoaneurysms of the hepatic arteries. The first case involved a pancreatic pseudocyst that ruptured in the duodenum and the second resulted in an intrahepatic hematoma that compressed the bile tract causing secondary hemobilia. Angiographic embolization was the primary treatment in both cases, with surgery for the first patient and later radiological drainage in the second. The hemorrhage was controlled in both cases despite the severe prognosis and high mortality in these cases.


Subject(s)
Aneurysm, False/etiology , Hepatic Artery/pathology , Pancreatitis, Chronic/complications , Adult , Aneurysm, Ruptured/etiology , Duodenal Ulcer/etiology , Embolization, Therapeutic , Hematoma/etiology , Hemobilia/etiology , Humans , Liver Diseases/etiology , Male , Middle Aged , Pancreatic Pseudocyst/complications , Pancreaticoduodenectomy , Peptic Ulcer Hemorrhage/etiology
11.
Am J Transplant ; 7(2): 448-53, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17173661

ABSTRACT

We conducted a study to evaluate the efficacy of pegylated interferon/ribavirin in patients who did not respond to previous posttransplant recurrent HCV treatment with IFN/ribavirin combination. Twenty-seven patients were consecutively included in this study and retreated with pegylated interferon alfa-2b (1.5 microg/kg/week) with ribavirin (800-1000 mg daily) for 48 weeks for genotype 1 and 4 and 24 weeks for other genotypes. We compared them with 21 untreated patients enrolled during the same period. Primary endpoint was the SVR and secondary endpoint was histological evaluation 24 weeks after ending therapy. Twenty-seven patients started therapy but 2 (7%) stopped because of side effects. On an intent-to-treat basis, eight patients (30%) had an SVR. Cyclosporine as immunosuppressive therapy during antiviral therapy (p = 0.03) and EVR (p = 0.02) were significantly associated with viral clearance. In 46 patients in whom paired graft biopsies were available, fibrosis score was improved in 76% of treated patients versus 5% in untreated patients. Among treated patients, improvement of fibrosis was not correlated to SVR. Our data show that 30% of patients who have failed prior posttransplantation treatment achieved an SVR when retreated with pegylated interferon alfa-2b/ribavirin. More interesting is that fibrosis score was improved in 65% of treated patients despite failure of HCV eradication.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C/etiology , Hepatitis C/prevention & control , Interferon-alpha/therapeutic use , Liver Cirrhosis/pathology , Liver Transplantation/adverse effects , Ribavirin/therapeutic use , Adult , Antiviral Agents/adverse effects , Biopsy , Drug Therapy, Combination , Female , Graft Rejection/prevention & control , Humans , Interferon alpha-2 , Interferon-alpha/adverse effects , Liver/pathology , Liver Transplantation/pathology , Male , Middle Aged , Polyethylene Glycols , Recombinant Proteins , Ribavirin/adverse effects , Secondary Prevention
12.
Ann Chir ; 131(3): 177-82, 2006 Mar.
Article in French | MEDLINE | ID: mdl-16527242

ABSTRACT

The aim of this study was to review the literature about the effect of antireflux surgery on the metaplasia-dysplasia-adenocarcinoma sequence in patients with Barrett's oesophagus. Antireflux operations (by laparotomy or laparoscopy) can alter the natural history of Barrett's oesophagus, allowing disease stabilization in a substantial proportion of patients without high grade dysplasia at time of surgery. It also may induce complete or partial regression of Barrett's epithelium, especially for short segment of Barrett's oesophagus, but in unpredictable manner. While regression of low-grade dysplasia is commonly observed, histologic progression is rarely observed after effective antireflux surgery. However, ineffective antireflux surgery expose to histologic progression to high-grade dysplasia or adenocarcinoma. These data support the need for a long-term clinical, endoscopic, and histologic follow-up program after antireflux surgery in patients with Barrett's oesophagus.


Subject(s)
Adenocarcinoma/prevention & control , Barrett Esophagus/surgery , Digestive System Surgical Procedures , Esophageal Neoplasms/prevention & control , Adenocarcinoma/etiology , Cell Transformation, Neoplastic , Esophageal Neoplasms/etiology , Gastroesophageal Reflux/etiology , Gastroesophageal Reflux/surgery , Humans , Precancerous Conditions , Treatment Outcome
13.
HPB (Oxford) ; 8(6): 465-73, 2006.
Article in English | MEDLINE | ID: mdl-18333103

ABSTRACT

OBJECTIVES: The object of our study was to report on the experience with vascular resections at pancreatectomy in two European specialist hepatopancreatobiliary centres and evaluate outcome and prognostic factors. PATIENTS AND METHODS: From 1989 to 2002, 45 patients (21 men, 24 women) underwent pancreatectomy for a pancreatic mass: Whipple's procedure (n=33), total pancreatectomy (n=10) or left splenopancreatectomy (n=2), along with a vascular resection, i.e. venous (n=39), arterial (n=1) or venous + arterial (n=5). RESULTS: Operative mortality was nil, postoperative mortality was 2.2% (n=1); 34 patients had an uneventful postoperative course. Reoperations were performed for portal vein thrombosis (n=1), pancreatic leak (n=1), gastric outlet syndrome (n=1) and gastrointestinal bleeding (n=1). In all, 43 patients had cancer on pathology examination, with retropancreatic invasion in 72% and lymph node extension in 62.8%. Resection was R0 in 21 cases. Vessel wall invasion was present in 13 cases and 19 had perivascular invasion. Disease-free survival (DFS) at 1, 2 and 3 years was 36.0%, 15.0% and 12.0%, respectively. Median DFS length was 8.7 months (95% CI: 7.2; 10.2). Overall survival rates were 56.6%, 28.9% and 19.2%, respectively. Median survival length was 14.2 months (95% CI: 9.8; 18.6). A multivariate analysis of prognostic variables identified tumour location (other than head of pancreas), neoadjuvant chemotherapy and advanced disease stage as adverse factors for DFS. CONCLUSION: Survival and DFS rates of these patients are comparable to those without vascular resection. Tumour localization, tumour stage, neoadjuvant treatment and tumour recurrence are explanatory variables of survival. Tumour localization, tumour stage and neoadjuvant treatment were explanatory variables for DFS. However, the type and extent of vascular resections as well as vessel wall invasion does not affect survival and DFS.

14.
J Chir (Paris) ; 143(6): 355-65, 2006.
Article in French | MEDLINE | ID: mdl-17285081

ABSTRACT

This study reviews current data regarding duodenogastric and gastroesophageal bile reflux-pathophysiology, clinical presentation, methods of diagnosis (namely, 24-hour intraluminal bile monitoring) and therapeutic management. Duodenogastric reflux (DGR) consists of retrograde passage of alkaline duodenal contents into the stomach; it may occur due to antroduodenal motility disorder (primary DGR) or may arise following surgical alteration of gastoduodenal anatomy or because of biliary pathology (secondary DGR). Pathologic DGR may generate symptoms of epigastric pain, nausea, and bilious vomiting. In patients with concomitant gastroesophageal reflux, the backwash of duodenal content into the lower esophagus can cause mixed (alkaline and acid) reflux esophagitis, and lead, in turn, to esophageal mucosal damage such as Barrett's metaplasia and adenocarcinoma. The treatment of DGR is difficult, non-specific, and relatively ineffective in controlling symptoms. Proton pump inhibitors decrease the upstream effects of DGR on the esophagus by decreasing the volume of secretions; promotility agents diminish gastric exposure to duodenal secretions by improving gastric emptying. In patients with severe reflux resistant to medical therapy, a duodenal diversion operation such as the duodenal switch procedure may be indicated.


Subject(s)
Duodenogastric Reflux , Gastroesophageal Reflux , Anion Exchange Resins/therapeutic use , Anti-Ulcer Agents/therapeutic use , Barrett Esophagus/etiology , Barrett Esophagus/physiopathology , Bile Acids and Salts/analysis , Cholecystectomy/adverse effects , Cholestyramine Resin/therapeutic use , Chromatography, High Pressure Liquid , Cisapride/therapeutic use , Duodenogastric Reflux/diagnosis , Duodenogastric Reflux/etiology , Duodenogastric Reflux/physiopathology , Duodenogastric Reflux/surgery , Duodenogastric Reflux/therapy , Duodenum/surgery , Esophagitis, Peptic/etiology , Esophagitis, Peptic/physiopathology , Gastric Acidity Determination , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/etiology , Gastroesophageal Reflux/physiopathology , Gastroesophageal Reflux/therapy , Gastrointestinal Agents/therapeutic use , Gastroplasty , Helicobacter Infections/complications , Helicobacter pylori , Humans , Hydrogen-Ion Concentration , Proton Pump Inhibitors , Risk Factors , Stomach Neoplasms/etiology , Sucralfate/therapeutic use
15.
Ann Chir ; 130(8): 491-4, 2005 Sep.
Article in French | MEDLINE | ID: mdl-16084484

ABSTRACT

Gastrojejunocolic fistulae, ultimate complication of anastomotic peptic ulceration, are presently uncommon. We report two recent cases of postoperative gastrojejunocolic fistulas (after duodenal ulcer surgery and total duodenopancreatectomy), which were complicated at time of diagnosis (acute peritonitis and liver cirrhosis) and required a two-stage treatment.


Subject(s)
Digestive System Surgical Procedures/methods , Gastric Fistula/pathology , Gastric Fistula/surgery , Jejunal Diseases/pathology , Jejunal Diseases/surgery , Aged , Female , Gastric Fistula/complications , Humans , Jejunal Diseases/complications , Liver Cirrhosis/etiology , Malabsorption Syndromes/etiology , Middle Aged , Peptic Ulcer/complications , Peritonitis/etiology
16.
Ann Oncol ; 16(9): 1488-97, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15939717

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the efficacy of adjuvant chemotherapy after resection for gastric cancer in a randomized controlled trial. PATIENTS AND METHODS: After curative resection, stage II-III-IVM0 gastric cancer patients were randomly assigned to postoperative chemotherapy or surgery alone. 5-Fluorouracil (5-FU) 800 mg/m(2) daily (5-day continuous infusion) was initiated before day 14 after resection. One month later, four 5-day cycles of 5-FU (1 g/m(2) per day) plus cisplatin (100 mg/m(2) on day 2) were administered every 4 weeks. RESULTS: The study was closed prematurely after enrollment of 260 patients (79.7% N+), owing to poor accrual. At 97.8 months median follow-up, 5- and 7-year overall survival were 41.9% and 34.9% in the control group versus 46.6% and 44.6% in the chemotherapy group (P=0.22). Cox model hazard ratios were 0.74 [95% confidence interval (CI) 0.54-1.02; P=0.063] for death and 0.70 (95% CI 0.51-0.97; P=0.032) for recurrence. An invaded/removed lymph nodes ratio >0.3 was the main independent poor prognostic factor identified by multivariate analysis (P=0.0001). Because of toxicity, only 48.8% of patients received more than 80% of the planned dose. CONCLUSION: There was no statistically significant survival benefit with this toxic cisplatin-based adjuvant chemotherapy, but a risk reduction in recurrence was observed.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Stomach Neoplasms/surgery , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Survival Analysis
17.
Med Trop (Mars) ; 65(1): 80-6, 2005.
Article in French | MEDLINE | ID: mdl-15903083

ABSTRACT

Is the new surgical training program at the University of Phom-Penh, Cambodia a unique experience or can it serve as a model for developing countries? This report describes the encouraging first results of this didactic and hands-on surgical program. Based on their findings the authors recommend not only continuing the program in Phom-Penh but also proposing slightly modified versions to new medical universities not currently offering specialization in surgery.


Subject(s)
Education, Medical, Graduate/methods , General Surgery/education , Cambodia , Developing Countries
18.
Ann Chir ; 130(4): 242-8, 2005 Apr.
Article in French | MEDLINE | ID: mdl-15847859

ABSTRACT

AIM OF THE STUDY: To report a series of 17 patients operated for a complication oesophagocoloplasty, with evaluation of therapeutic modalities, and both early and distant results. MATERIALS AND METHOD: From 1985 to 2003, 17 patients with a mean age of 50 years (range: 23-76) were reoperated after coloplasty pediculated on left superior colic vessels. Initial diseases were caustic ingestion (N=7), cancer (N=6), oesophageal perforation (N=2), gastric lymphoma (N=1) and oesotracheal fistula (N=1). Coloplasty has been performed as a first-intent procedure in 13 cases and as a second-intent procedure after failure of a previous operation in 4 cases. Nine patients were initially operated in another center and were subsequently referred in our unit. Complications needing reoperation were graft necrosis in 8 cases (47%) and stricture in 9 cases (53%). All patients with necrosis were reoperated within the 10 first postoperative days. RESULTS: Necroses were treated by complete (N=5) or partial (N=3) resection of the coloplasty. Strictures were treated by resection-reanastomosis (N=3), right ileocoloplasty (N=2), colic stricturoplasty (N=2), a free antebrachial flap (N=1) and a tubulized latissimus dorsi myocutaneous pedicled flap (N=1). The 30-day mortality rate was 12% (N=2) and the overall morbidity rate was 66%. All deaths occurred after reoperation for necrosis. Eleven patients (65%) kept or recovered digestive continuity (including the 9 with stenosis) and 8 (73%) eat normally. Four patients with transplant necrosis died before reestablishment. Four patients operated for necrosis died before restoration of digestive continuity and 2 patients are still awaiting restoration. CONCLUSION: Use of colon as an oesophageal substitute is risky. Reoperations for stenosis allows satisfactory oral feeding, while reoperation for necrosis is associated with both high early mortality and a low rate of restoration or digestive continuity. This later requires a range of complex surgical procedures.


Subject(s)
Colonic Neoplasms/surgery , Esophageal Neoplasms/surgery , Esophagoplasty/adverse effects , Esophagoplasty/methods , Plastic Surgery Procedures/methods , Postoperative Complications/surgery , Adult , Aged , Esophageal Stenosis/etiology , Esophagoplasty/mortality , Female , Humans , Male , Middle Aged , Morbidity , Necrosis , Reoperation , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...